Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples